The Management of Type 2 Diabetes

An enduring offering of the The New York State Medicaid Prescriber Education Program.

Accreditation: ACCME for prescribers and ACPE for pharmacists

Contact Hours 1.5 (0.15 CEUs)

Target Audience

Physicians, physician assistants, nurse practitioners, pharmacists and other health care providers

Why Attend

According to CDC, the number of people with diabetes has more than tripled in the last couple of decades, reaching around 30 million in 2015. There are 1.5 million Americans diagnosed with new cases of diabetes every year. The economic cost of diabetes increases each year. In 2017, the total costs of diagnosed diabetes in the United States was $327 billion, $237 billion was for direct medical costs, and $90 billion in estimated reduced productivity.

In 2015, About 84 million Americans age 18 and older had prediabetes, due to these alarming numbers, it is important to increase the efforts with regards to early detection in prediabetic patients. Early detection and working with the patient can delay the onset or prevent type 2 diabetes and reduce health care cost. The CDC provides programs and incentives in which implements a high-impact prevention approach to reducing new diabetes cases via the combinations of various interventions and prevention strategies directed towards the US populations that are most affected by, or at greatest risk for, diabetes.

Objectives

Define pre-diabetes and Type 2 Diabetes
Identify appropriate lifestyle modifications to manage diabetes
Determine individualized hemoglobin A1c (HbA1c) goals for patients based on American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) guidelines
Identify appropriate first and second line pharmacotherapy agents to achieve patients’ HbA1c goals
Identify when initiation of basal insulin may be an appropriate add-on therapy in patients with Type 2 diabetes
Define hypoglycemia and the management of this condition

Program Components

This program contains a pre-test, educational presentation, educational reference material, post-test, and program evaluation.

Credit will be awarded upon successful completion of the post-test activity, with a score of 70% or better.

Speaker(s)

Erlin J Marte, MD
Diabetes and Endocrinology Service at Buffalo Medical Group

Cost and Registration

There is no fee for prescribers for this activity. This program is supported by the New York State Department of Health Medicaid Prescriber Education Program (MPEP). For more information on the MPEP program, please visit https://nypep.nysdoh.suny.edu/

All others: General registration fee $25.00

Accreditation Information

Accreditation information for physicians/providers:

Course Code: 9086

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

CERTIFICATION

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this internet enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditaton information for pharmacists:

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE#0044-0000-19-039-H01-P and will award 1.5 contact hours (0.15 ceus) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity.

Initial Release Date: 03-30-2020 Expiration Date: 06-30-2022